The PI3K/mTOR inhibitor Gedatolisib eliminates dormant breast cancer cells in organotypic culture, but fails to prevent metastasis in preclinical settingsRyann E. Shor, Cyrus M. Ghajar|Molecular Oncology|2021Cited by 38